Frazier Management as of June 30, 2020
Portfolio Holdings for Frazier Management
Frazier Management holds 26 positions in its portfolio as reported in the June 2020 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Arcutis Biotherapeutics (ARQT) | 28.0 | $319M | 11M | 30.24 | |
| Phathom Pharmaceuticals (PHAT) | 16.8 | $192M | 5.8M | 32.91 | |
| Passage Bio (PASG) | 12.0 | $137M | 5.0M | 27.33 | |
| Vaxcyte (PCVX) | 6.4 | $73M | 2.3M | 31.61 | |
| Mirum Pharmaceuticals (MIRM) | 6.1 | $69M | 3.6M | 19.46 | |
| Anaptysbio Inc Common (ANAB) | 4.5 | $52M | 2.3M | 22.34 | |
| Translate Bio | 3.4 | $39M | 2.2M | 17.92 | |
| Krystal Biotech (KRYS) | 3.3 | $37M | 895k | 41.42 | |
| Iovance Biotherapeutics (IOVA) | 3.2 | $36M | 1.3M | 27.45 | |
| Adverum Biotechnologies | 2.6 | $30M | 1.4M | 20.88 | |
| Alpine Immune Sciences | 2.2 | $25M | 2.6M | 9.71 | |
| Trillium Therapeutics Com New | 2.0 | $22M | 2.8M | 8.09 | |
| Syndax Pharmaceuticals (SNDX) | 1.7 | $20M | 1.3M | 14.82 | |
| Collegium Pharmaceutical Inc Common Stock Usd (COLL) | 1.5 | $17M | 944k | 17.50 | |
| Gritstone Oncology Ord (GRTSQ) | 1.2 | $14M | 2.1M | 6.64 | |
| Aptinyx | 1.2 | $13M | 3.2M | 4.17 | |
| Iveric Bio | 1.1 | $12M | 2.4M | 5.10 | |
| Rocket Pharmaceuticals (RCKT) | 1.0 | $11M | 528k | 20.93 | |
| Allena Pharmaceuticals | 0.5 | $5.3M | 3.3M | 1.58 | |
| Cidara Therapeutics Inc Common Stock Usd 0.0001 | 0.4 | $4.8M | 1.3M | 3.69 | |
| Nabriva Therapeutics SHS | 0.3 | $2.9M | 4.3M | 0.67 | |
| Sierra Oncology Com New | 0.2 | $2.5M | 203k | 12.10 | |
| Vtv Therapeutics Cl A | 0.2 | $2.4M | 1.1M | 2.25 | |
| Iterum Therapeutics SHS | 0.2 | $1.8M | 1.5M | 1.19 | |
| Entasis Therapeutics Holdings Ord | 0.1 | $1.0M | 350k | 2.96 | |
| Bellicum Pharmaceuticals Com New | 0.1 | $781k | 105k | 7.43 |
